Deferiprone‐induced agranulocytosis: 20 years of clinical observations

Use of the iron chelator deferiprone for treatment of iron overload in thalassemia patients is associated with concerns over agranulocytosis, which requires weekly absolute neutrophil counts (ANC). Here, we analyze all episodes of agranulocytosis (n = 161) and neutropenia (n = 250) during deferipron...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricta, Fernando, Uetrecht, Jack, Galanello, Renzo, Connelly, John, Rozova, Anna, Spino, Michael, Palmblad, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129477/
https://www.ncbi.nlm.nih.gov/pubmed/27415835
http://dx.doi.org/10.1002/ajh.24479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129477/
https://www.ncbi.nlm.nih.gov/pubmed/27415835
http://dx.doi.org/10.1002/ajh.24479

Ejemplares similares